Related Experiment Video

Updated: Jun 13, 2026

Development and Application of Rapamycin-regulated Tyrosine Phosphatases
06:56

Development and Application of Rapamycin-regulated Tyrosine Phosphatases

Published on: September 6, 2024

Downregulation of Rap1GAP in human tumor cells alters cell/matrix and cell/cell adhesion

Oxana M Tsygankova1, Changqing Ma, Waixing Tang

  • 1Department of Pharmacology, University of Pennsylvania School of Medicine, 421 Curie Blvd., BRB II/III, Philadelphia, PA 19104-6061, USA.

Molecular and Cellular Biology
|May 5, 2010
PubMed

Insights

Downregulation of Rap1GAP in tumors impairs cell adhesion, promoting tumor progression. Restoring Rap1GAP function could offer therapeutic strategies against cancer metastasis.

Area of Science:

  • Cell Biology
  • Molecular Oncology
  • Biochemistry

Background:

  • Rap1GAP (Rap1 GTPase Activating Protein) expression is reduced in human tumors, but its functional significance remains unclear.
  • Decreased Rap1GAP levels are observed in primary colorectal carcinomas, suggesting a potential role in colorectal cancer development.

Purpose of the Study:

  • To investigate the functional consequences of Rap1GAP downregulation in human colon carcinoma cells.
  • To elucidate the mechanisms by which Rap1GAP loss affects cell adhesion, cell-matrix interactions, and signaling pathways.

Main Methods:

  • Rap1GAP expression was silenced in human colon carcinoma cells using gene silencing techniques.
  • Cell adhesion, adherens junction protein distribution, and cell spreading on collagen were analyzed.
  • The role of Rap signaling, integrin signaling, and Src activity was assessed through gene silencing and pharmacological inhibition.

Main Results:

  • Rap1GAP depletion led to significant defects in cell/cell adhesion and aberrant adherens junction protein distribution.
  • Loss of Rap1GAP enhanced cell adhesion and spreading on collagen, linked to unrestrained Rap activity.
  • Integrin signaling was crucial for Rap1GAP-depletion-induced adhesion defects, and Src activity was unexpectedly increased.

Conclusions:

  • Rap1GAP plays a critical role in regulating both cell/cell and cell/matrix adhesion.
  • Rap1GAP downregulation in tumors may contribute to tumor progression and metastasis by disrupting normal adhesion processes.
  • Targeting Rap1GAP or associated pathways like Src could represent a novel therapeutic strategy for epithelial cancers.

More Related Videos

Characterization of Cell Membrane Extensions and Studying Their Roles in Cancer Cell Adhesion Dynamics08:11

Characterization of Cell Membrane Extensions and Studying Their Roles in Cancer Cell Adhesion Dynamics

Published on: March 26, 2018

Examining the Dynamics of Cellular Adhesion and Spreading of Epithelial Cells on Fibronectin During Oxidative Stress10:57

Examining the Dynamics of Cellular Adhesion and Spreading of Epithelial Cells on Fibronectin During Oxidative Stress

Published on: October 13, 2019

Related Concept Videos

Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Cadherins in Tissue Organization01:19

Cadherins in Tissue Organization

The cadherins are a superfamily of cell adhesion molecules comprising over 180 variants, with specific tissues expressing a particular combination of cadherin types. Cadherins generally exhibit homophilic binding; i.e., cadherins on one cell bind to cadherins of the same or closely related type on another cell. Thus, cells of the same type have a specific affinity to bind to each other and sort themselves into clusters to form tissues.
Cell Sorting During Development
Cell sorting plays an...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...